Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone
Background and Objectives High-dose melphalan and autologous stem cell transplantation is currently the treatment of choice for selected patients with AL amyloidosis; however, new treatments are needed for patients who are ineligible for or relapse after this procedure. Bortezomib is a proteasome in...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Ferrata Storti Foundation
2007-10-01
|
| Colección: | Haematologica |
| Acceso en línea: | https://haematologica.org/article/view/4600 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|